SAN DIEGO, March 10, 2017 -- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that its Microwave Electronics Division (MED) recently received $13.7 million in contract awards related to specialized communication systems. MED is a leading provider of integrated microwave assemblies, solid state power amplifiers, GPS immune modules and other microwave electronic products that support radar, missile, electronic warfare, guidance, unmanned aerial and other systems. Work under these contract awards will be produced in a secure Kratos manufacturing facility. Due to customer related and other considerations, no additional information is being provided related to these contract awards.
About Kratos Defense & Security Solutions
Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS) is a mid-tier government contractor at the forefront of the Department of Defense's Third Offset Strategy. Kratos is a leading technology, intellectual property and proprietary product and solution company focused on the United States and its allies' national security. Kratos is the industry leader in high performance unmanned aerial drone target systems used to test weapon systems and to train the warfighter, and is a provider of high performance unmanned combat aerial systems for force multiplication and amplification. Kratos is also an industry leader in satellite communications, microwave electronics, cyber security/warfare, missile defense and combat systems. Kratos has primarily an engineering and technically oriented work force of approximately 2,900. Substantially all of Kratos' work is performed on a military base, in a secure facility or at a critical infrastructure location. Kratos' primary end customers are National Security related agencies. News and information are available at www.KratosDefense.com.
Notice Regarding Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Kratos and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Kratos undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Kratos believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Kratos in general, see these and other risk factors more fully discussed in the Company’s Annual Report on Form 10-K for the period ended December 25, 2016, and in our other filings made with the Securities and Exchange Commission.
Press Contact: Yolanda White 858-812-7302 Direct Investor Information: 877-934-4687 [email protected]


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



